Member Info for bigAl67

Have a Good day Investors - Sorry you have to put up with the Twisted Lies of Posters like 'Incognito the False'

I am going Fishing for the Day!!!

Just read Roger's post today over on BSFA, and the response his post received - I am surprised Roger is still invested here in GDR, considering the Ferocity of his attacks on our CEO?

roger65

Posts: 3,238

Price: 11.75

No Opinion

RE: Is this our competition?Today 11:52

In fact I've just chosen to dump some of my holding. 19,999 shares at 11.73p. Probably wrong decision but I'm losing confidence in the BODs so know what I must do...

Response:-

BuenaVista

Posts: 1,243

Price: 11.75

No Opinion

RE: Is this our competition?Today 16:55

Not got much of a time horizon have you Rog.

"The stock market is a device for transferring money from the impatient to the patient."

~ Warren Buffett

Looking like Large Trades of 100k - 250K, is possible, before Trades close today - Fingers crossed !! - Not going to say whether they will show as Buys or Sells, because they do not always appear as they perhaps should - so let others decide LOL

100k Trade is close to my hunch/theory - especially if it gets reversed to a Buy on Monday LOL

Have a Great week end everyone !!

Just a hunch and a theory - will be interesting if it happens lol

Looking like 150k - 250K of Buys, is possible, before Trades close today - Fingers crossed !!

Great Confirmation Post Jimi,

Thanks for requesting Confirmation and Posting here!!

RF Must be certain of making Big money through their initial share allocation and the warrants, and cannot have been selling recently either, as some would have us believe LOL

They are not financing us for the 4% commission that is for sure !!!!

Hi MyIPA,

Agreed, and I concur:-

From the RNS:-

''Investors have been granted 682,730 warrants equal to 40% of this drawdown divided by the Reference Price of 17.57648 pence. The exercise price of the warrants payable to the Company will be 140% of the Reference Price equating to 24.6071 pence.''

So how does this work out:-

40% of this drawdown = 40% of £300,000 = 120,000, and 120,000 divided by the reference price of 17.57648 pence = 682,730 warrants

The exercise price of these 682,730 warrants is 140% of the reference price of 17.57648p = 140% x 17.57648 = 24.6071p payable to the company.

Therefore 682,730 warrants x 24.6071p = £168,000

LOL - starres our resident 'Non Shareholder' - Still Posting HIS Rubbish - This last post of his IS ONE to save, and play back on our BB - LOL

LSE:-

Share Price: 18.50 Bid: 17.50 Ask: 19.50

31 Mar 2023 18:32

RNS Number : 0323V

Future News Flow

Within the next six months, the Company expects to sign additional distribution partners for Genedrive® MT-RNR1, establish additional go-live sites in the UK for Genedrive® MT RNR1, promote and launch the Genedrive® MT RNR1 assay in other EU countries (following language translations and any country specific product registrations) and launch/ be close to launch of Genedrive® CYP2C19 in the UK post receipt of UKCA mark.

The Company estimates that the total addressable UK market is up to £8.5 million per annum which is based on approximately 85,000 ischaemic strokes per annum. The EU market is potentially another c. £93.5 million per annum (c. 800,000 strokes per annum), the U.S. market is c. £67.6 million per annum (c. 700,000 strokes per annum) and rest of world markets c. £51.0 million per annum. The Company anticipates the customer price to be approximately £100 per test.

31 Mar 2023 18:32

RNS Number : 0323V

The Company sees attractive short and long term revenue opportunities for its novel AIHL test for use in neonatal acute care settings and also for the CYP2C19 test, a point of care product with a number of performance differentiating features which is in the final stages of development and which the Company is now planning to launch in the United Kingdom circa September/October 2023.

Hi stephen11,

NICE's final guidance on the Genedrive® MT-RNR1 ID Kit will follow a public consultation period which opens today, 9 February and closes on 21 February 2023. The final recommendations will be the basis for NICE's early value guidance on using the Genedrive® MT-RNR1 test in NHS England alongside additional data generation.

I have just checked the RNS list, and I cannot see an RNS published on completion of the MT-RNR1 ID KIT consultation period, on the 21st February 2023.

It was on the 30th March that NICE released an RNS:-

30 Mar 2023 07:00

RNS Number : 6932U

Genedrive® MT-RNR1 ID Test receives positive final recommendation by NICE

NICE issues final guidance for use in the NHS through Early Value Assessment programme

However, our CYP2C19 is in a different state, in that it is still in Development, and therefore different timelines may well apply ?

Hi stephen11,

Yes - On the day the NICE consultation period started, an RNS was released:- 19 May 2023 07:00 RNS Number : 9399Z – a Quote from this RNS: -

‘‘NICE's final guidance will follow the public consultation period which opens today, 19 May, and is scheduled to close on 9 June 2023’’

Hi Jimi,

Yes I agree, and the RNS only refers to the warrants,

However, the RNS also refers to the original '£5 million Equity Prepayment Facility' RNS issued on the 31st March - so details of New shares issued must be included there?

Hi Jimi,

The RNS states that the Investors (RF) have been granted warrants:-

From the RNS:-

''Investors have been granted 682,730 warrants equal to 40% of this drawdown divided by the Reference Price of 17.57648 pence. The exercise price of the warrants payable to the Company will be 140% of the Reference Price equating to 24.6071 pence.''

So how does this work out:-

40% of this drawdown = 40% of £300,000 = 120,000, and 120,000 divided by the reference price of 17.57648 pence = 682,730 warrants

The exercise price of these 682,730 warrants is 140% of the reference price of 17.57648p = 140% x 17.57648 = 24.6071p payable to the company.

Therefore 682,730 warrants x 24.6071p = £168,000

Google states:-

How do share warrants work?

A stock warrant is a type of derivative that gives the holder the right to buy a share of a company for a specific price within a set window of time or on a specific date. Companies will often issue them to raise capital, or as an employee benefits, recruitment or retention package

Still did not post? Try again

incognito then posted again - Re Eureka < 2 hours later

''You said there would be an RNS today and your contact guaranteed it so you was lying, you are now trying to shift the goal posts''

''I wish you was right so the SP would increase, I'm not happy your lying, just funny you are trying to save face after being caught out'' - posted at 09:01 on the 17th of May 2023.

incognito posted today at 08:32 - ''Eureka who is insulting anyone? You guaranteed news on a certain day, and it was wrong why are you so bitter about me laughing at that a month ago lol''

''I questioned you at the time and it caused a few tantrums''

The above proves that Eureka did not Lie. It is obvious who is posting Lies - And it is not Eureka - QED

Still did not post ? try again:-

incognito then posted again - Re Eureka

Clarification continued - sorry the complete post, did not post

incognito then posted again - Re Eureka

Clarification continued:-

incognito then posted again - Re Eureka